Dr Sufyan Hussain
Honorary Reader and Consultant Diabetes Physician
Biography
I am a UKRI/MRC-funded clinician-scientist with a specialist interest in translational research and implementation of novel therapies and technologies for type 1 diabetes. My research focus includes hybrid-closed loop systems and cell therapy (islet and stem-cell transplantation) for type 1 diabetes. I have several ongoing studies on these themes and strong collaborations with colleagues researching topics including artificial intelligence and psychological well-being in people with type 1 diabetes. Outside research and clinical work, as a board member of the International Diabetes Federation-Europe and vice-chair for the UK’s Association of British Clinical Diabetologists Diabetes Technology Network, I maintain roles in policy, strategy and advocacy for diabetes. I am interested in supporting candidates for higher research degrees (MD, PhD).
Research
Islet Biology Research Group
Our group studies the fundamental science of islets of Langerhans, from the molecular biology of beta-cells to their effects on whole body physiology. We research the mechanisms of islet dysfunction during type 2 diabetes and gestational diabetes, identify novel therapeutic targets, and work to improve islet transplantation therapy for type 1 diabetes.
Type 1 Diabetes Research Group
We are experimental medicine researchers and clinical academics performing mechanistic and clinical studies, using qualitative, quantitative and neuroimaging techniques, and clinical trials to investigate aspects of diabetes, including mechanisms and treatment of hypoglycaemia, eating disorders and appetite control.
Optimising the Delivery of Diabetes Distress-Informed Care for its Prevention, Detection and Management in Adults with Type 1 Diabetes: A Hybrid Effectiveness-Implementation Programme (D-stress Study)
The D-stress study develops a new programme that combines the best of three existing treatments to detect, manage and prevent type 1 diabetes distress in the UK
Project status: Ongoing
Research
Islet Biology Research Group
Our group studies the fundamental science of islets of Langerhans, from the molecular biology of beta-cells to their effects on whole body physiology. We research the mechanisms of islet dysfunction during type 2 diabetes and gestational diabetes, identify novel therapeutic targets, and work to improve islet transplantation therapy for type 1 diabetes.
Type 1 Diabetes Research Group
We are experimental medicine researchers and clinical academics performing mechanistic and clinical studies, using qualitative, quantitative and neuroimaging techniques, and clinical trials to investigate aspects of diabetes, including mechanisms and treatment of hypoglycaemia, eating disorders and appetite control.
Optimising the Delivery of Diabetes Distress-Informed Care for its Prevention, Detection and Management in Adults with Type 1 Diabetes: A Hybrid Effectiveness-Implementation Programme (D-stress Study)
The D-stress study develops a new programme that combines the best of three existing treatments to detect, manage and prevent type 1 diabetes distress in the UK
Project status: Ongoing